These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
719 related articles for article (PubMed ID: 28535511)
1. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis. Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511 [TBL] [Abstract][Full Text] [Related]
2. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501 [TBL] [Abstract][Full Text] [Related]
3. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway. Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697 [TBL] [Abstract][Full Text] [Related]
4. Circular RNA ABCB10 promotes cell proliferation and invasion, but inhibits apoptosis via regulating the microRNA‑1271‑mediated Capn4/Wnt/β‑catenin signaling pathway in epithelial ovarian cancer. Lin X; Chen Y; Ye X; Xia X Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760208 [TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y; Dun Y; Zhou S; Huang XH Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819 [TBL] [Abstract][Full Text] [Related]
6. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling. Ren W; Wang D; Li C; Shu T; Zhang W; Fu X Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway. Zhuang XH; Liu Y; Li JL Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688 [TBL] [Abstract][Full Text] [Related]
8. Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/β-catenin pathway. Wang E; Wang D; Li B; Ma H; Wang C; Guan L; Zhang H; Yi L; Li S Oncol Rep; 2017 Jan; 37(1):379-387. PubMed ID: 27878263 [TBL] [Abstract][Full Text] [Related]
9. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer. Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316 [TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma. Burkhalter RJ; Westfall SD; Liu Y; Stack MS J Biol Chem; 2015 Sep; 290(36):22143-54. PubMed ID: 26175151 [TBL] [Abstract][Full Text] [Related]
11. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer. Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012 [TBL] [Abstract][Full Text] [Related]
12. Capn4 promotes esophageal squamous cell carcinoma metastasis by regulating ZEB1 through the Wnt/β-catenin signaling pathway. Zhao YL; Li JB; Li YJ; Li SJ; Zhou SH; Xia H Thorac Cancer; 2019 Jan; 10(1):24-32. PubMed ID: 30444080 [TBL] [Abstract][Full Text] [Related]
13. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis. Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130 [TBL] [Abstract][Full Text] [Related]
14. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells. Barghout SH; Zepeda N; Xu Z; Steed H; Lee CH; Fu Y Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):173-8. PubMed ID: 26522223 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway. Wei C; Zhang X; He S; Liu B; Han H; Sun X Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein drives multiple cross-talk cascade loops involving NF-κB, 5-LOX, OPN and Capn4 to promote cell migration. Zhang X; You X; Wang Q; Zhang T; Du Y; Lv N; Zhang Z; Zhang S; Shan C; Ye L; Zhang X PLoS One; 2012; 7(2):e31458. PubMed ID: 22355367 [TBL] [Abstract][Full Text] [Related]
17. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway. Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968 [TBL] [Abstract][Full Text] [Related]
18. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
19. Capn4 promotes colorectal cancer cell proliferation by increasing MAPK7 through activation of the Wnt/β-Catenin pathway. Cheng F; Mohanmed MM; Li Z; Zhu L; Zhang Q; Huang Q; Shen W Exp Cell Res; 2018 Feb; 363(2):235-242. PubMed ID: 29331389 [TBL] [Abstract][Full Text] [Related]
20. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance. Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]